Follow-up of patch test reactivity to sesquiterpene lactone mix in a patient successfully treated with dupilumab for severe airborne allergic contact dermatitis.

Contact DermatitisVolume 89, Issue 2 p. 140-141 LETTER TO THE EDITOR Follow-up of patch test reactivity to sesquiterpene lactone mix in a patient successfully treated with dupilumab for severe airborne allergic contact dermatitis Rosella Gallo, Corresponding Author Rosella Gallo [email protected] Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Correspondence Rosella Gallo, Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Email: [email protected] Contribution: Conceptualization, Writing - original draft, Methodology, Validation, Writing - review & editing, SupervisionSearch for more papers by this authorIlaria Trave, Ilaria Trave Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Contribution: ​Investigation, Writing - original draft, Writing - review & editing, Validation, MethodologySearch for more papers by this authorRiccardo Castelli, Riccardo Castelli Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Contribution: ​Investigation, Validation, VisualizationSearch for more papers by this authorGiulia Gasparini, Giulia Gasparini Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Contribution: Validation, Visualization, ​InvestigationSearch for more papers by this authorAurora Parodi, Aurora Parodi Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Contribution: Visualization, Validation, SupervisionSearch for more papers by this author Rosella Gallo, Corresponding Author Rosella Gallo [email protected] Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Correspondence Rosella Gallo, Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Email: [email protected] Contribution: Conceptualization, Writing - original draft, Methodology, Validation, Writing - review & editing, SupervisionSearch for more papers by this authorIlaria Trave, Ilaria Trave Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Contribution: ​Investigation, Writing - original draft, Writing - review & editing, Validation, MethodologySearch for more papers by this authorRiccardo Castelli, Riccardo Castelli Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Contribution: ​Investigation, Validation, VisualizationSearch for more papers by this authorGiulia Gasparini, Giulia Gasparini Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Contribution: Validation, Visualization, ​InvestigationSearch for more papers by this authorAurora Parodi, Aurora Parodi Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy Contribution: Visualization, Validation, SupervisionSearch for more papers by this author First published: 12 June 2023 https://doi.org/10.1111/cod.14367 Rosella Gallo and Ilaria Trave contributed equally to this study. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1Muñoz-Bellido FJ, Moreno E, Dávila I. Dupilumab: a review of present indications and off-label uses. J Investig Allergol Clin Immunol. 2022; 32: 97- 115. 2Dhingra N, Shemer A, Correa da Rosa J, et al. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol. 2014; 134: 362- 372. 3Ludwig CM, Krase JM, Shi VY. T helper 2 inhibitors in allergic contact dermatitis. Dermatitis. 2021; 32: 15- 18. 4Raffi J, Suresh R, Botto N, Murase JE. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: a retrospective chart review. J Am Acad Dermatol. 2020; 82(1): 132- 138. 5Jo CE, Mufti A, Sachdeva M, Pratt M, Yeung J. Effect of dupilumab on allergic contact dermatitis and patch testing. J Am Acad Dermatol. 2021; 84: 1772- 1776. 6Gallo R, Oddenino G, Trave I, Gasparini G, Guadagno A, Parodi A. Contact sensitivity to sesquiterpene lactone mix and artichoke in a patient with severe recurrent dermatitis: a puzzling case. Contact Dermatitis. 2023; 88: 156- 158. 7Ruge IF, Skov L, Zachariae C, Thyssen JP. Dupilumab treatment in two patients with severe allergic contact dermatitis caused by sesquiterpene lactones. Contact Dermatitis. 2020; 83: 137- 139. Volume89, Issue2August 2023Pages 140-141 ReferencesRelatedInformation